NCT03383016Active, not recruiting
Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)
Interaction Between Environment, Diet, Physical Activities, and Sexual Habits, in the Risk of Prostate Cancer. Validation of Biomarkers to Personalize Preventive Interventions (BIOCaPPE)
Source: ClinicalTrials.gov · Last updated 30 Dec 2025
Brief summary (registry, in English)
The risk of prostate cancer is associated with lifestyle habits, such as diet and physical activity. Indeed, results of numerous studies suggest links between obesity, diabetes, inflammation and androgen and estrogen metabolism in the pathogenesis of prostate cancer. The goal of BIOCaPPE study (Biomarkers and Prostate Cancer/ Prevention and Environment) is to identify biomarkers of prostate cancer risk that are potentially modifiable by environmental exposures (e.g. diet and physical activity). A selection of few of the most promising biological markers will be evaluated in a cohort of more than 2000 men at high-risk of prostate cancer. Such biomarkers would provide a practical approach to identify men at high risk of prostate cancer who could benefit from interventions aiming at reducing their risk. The biomarkers would also be useful to monitor the efficacy of the interventions on patient's lifestyle.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 2053 (actual)
- First submitted
- 5 Dec 2017
- Start date
- 20 Jun 2013
- Primary completion date
- 23 Sept 2022
- Lead sponsor
- CHU de Quebec-Universite Laval
- Diseases
- Prostate cancer
- NCT number
- NCT03383016
What you commit to
- Study type: Observational
- Participants enrolled: 2053
- From 20 Jun 2013 to the primary completion date, 23 Sept 2022
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Positive result for transurethral prostatic resection
Other illness
- Prostate cancer
Who the study is looking for
- Group 1: A first negative prostate biopsy within 6 months
- Group 2: serum-PSA level between 2.5-10 ng/mL and no prior prostate biopsy
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre de recherche du Centre hospitalier de l'Université de Montréal Coordinator of this site? Confirm its status | Montreal | Canada | Unknown status |
| McGill University Health Center Coordinator of this site? Confirm its status | Montreal | Canada | Unknown status |
| CHU de Quebec-Universite Laval Coordinator of this site? Confirm its status | Québec | Canada | Unknown status |
| Centre de recherche du Centre hospitalier universitaire de Sherbrooke Coordinator of this site? Confirm its status | Sherbrooke | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.